Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 105,579 | 126,413 | 104,579 | 89,548 | 81,816 |
| Cost of Goods | 79,363 | 92,515 | 80,198 | 64,847 | 58,521 |
| Gross Profit | 26,216 | 33,898 | 24,381 | 24,701 | 23,295 |
| Operating Expenses | 30,731 | 28,170 | 24,569 | 19,381 | 22,587 |
| Operating Income | -4,152 | 6,243 | 10 | 6,167 | 1,229 |
| Interest Expense | 7,136 | 6,805 | 6,318 | 3,179 | 3,036 |
| Other Income | -997 | 319 | 798 | 634 | 469 |
| Pre-tax Income | -12,285 | -243 | -5,510 | 3,622 | -1,338 |
| Income Tax | -2,218 | -2,028 | -1,340 | 1,315 | 885 |
| Net Income Continuous | -10,067 | 1,785 | -4,170 | 2,307 | -2,223 |
| Net Income | $-10,067 | $1,785 | $-4,170 | $2,307 | $-2,223 |
| EPS Basic Total Ops | -0.29 | 0.05 | -0.12 | 0.07 | -0.07 |
| EPS Basic Continuous Ops | -0.29 | 0.05 | -0.12 | 0.07 | -0.07 |
| EPS Diluted Total Ops | -0.29 | 0.05 | -0.12 | 0.07 | -0.07 |
| EPS Diluted Continuous Ops | -0.29 | 0.05 | -0.12 | 0.07 | -0.07 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.05 | 0.11 | N/A | N/A |
| EBITDA(a) | $5,341 | $15,593 | $5,268 | $15,325 | $6,982 |